ISTH 2020 Congress Archives - ISTH Congress Abstracts

Abstract Number: PB0650

Validation of a New Point-of-Care Platelet Counter

M. Nagy¹, R. van Oerle¹, S. Fazaeli², J. Sherry², P.L.A. Giesen³, C. Lauwerijssen², G. Mimnagh², H. ten Cate¹, H.M. Spronk¹
Abstract Number: PB0168

Validation of a Non- Sensitive aPTT Reagent for the Presence of Anti-Phospholipid Abs (Lupus Anti-Coagulant)

S. Nakav¹, Y. Sulayev², T. Mendez², A. Bragg¹, A. Ben-Dor², I. Pickholtz¹, I. Kat²
Abstract Number: PB0568

Validation of a Warfarin Dose Prediction Model: A Single Center Retrospective Study

A. Lubetsky^1,2, O. Cohen^1,2, G. Kenet^1,2
Abstract Number: PB1011

Validation of an Algorithm to Identify Hemophilia A Patients in Administrative Database

A.U. Alam, M. Karkhaneh, C. Wu, H. Sun
Abstract Number: PB0685

Validation of the Atellica COAG 360 Coagulation Analyzer

E. Krstova Krajnc, M. Šega
Abstract Number: PB0692

Validation of the ROTEM PLATELET® Module as an Impedance Platelet Aggregation Test Compared to the Gold Standard Test: Conventional Platelet Aggregation

J. Guerra, V.F. Aranda, M.M.S. Oliveira, A.O. Santos, D.R.C. Mello, C.E.A. Mendes, B.G.N. Fogo, M. Oliveira, C.M. Ito, E.R.L.S. Junior, O. Ricardi, R.M.C. Penteado
Abstract Number: PB1253

Validity and Reliability of Self-Administered Thai Pediatric Bleeding Questionnaire (TPBQ) Application to Predict Risk of Bleeding in Pediatric Bleeding Disorders

S. Suwanwijit, D. Sosothikul
Abstract Number: PB1033

Value of Super Microvascular Imaging and Contrast-enhanced Ultrasound in Evaluating the Neovascularization of Synovial Hypertrophy in Hemophilia Joints

Y. Li¹, Y. Zhang¹, C. Xu¹, J. Sun², Y. Gao¹, H. Liu¹, M. Fei¹
Abstract Number: PB0622

Variability in Dabigatran and Apixaban trough Concentrations

P. Della Valle¹, L. Pozzi², E. Pattarini³, L. Tomassini¹, A. Fattorini¹, L. Crippa¹, A. D'Angelo¹
Abstract Number: PB1239

Variability in Diagnosis and Management of Immune Thrombocytopenia in Children: Real Life According to Spanish Pediatricians and Hematologists

R. Berrueco^1,2, J.L. Dapena³, E. Monteagudo⁴, I. Astigarraga⁵, A. Cervera⁶, M.A. Dasí⁷, A. Sastre⁸, E. Sebastian⁹
Abstract Number: PB2430

Variability in Exposure to Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Hospitalised Patients

E. Kampouraki¹, P. Avery², H. Wynne³, F. Kamali^1,3
Abstract Number: PB1672

Variability in Platelet Function among Patients with von Willebrand Disease Type 2B (VWD2B): Focus on Patients Historically Diagnosed with Montreal Platelet Syndrome (Historic-MPS)

M. Rand¹, P. James², H. Wang¹, K.W.A. Bang³, M. Bowman², S. Cloutier⁴, S. Jackson⁵, M.-C. Poon⁶
Abstract Number: PB2392

Variability of Management of Peripheral Catheter-Related Upper Extremity Superficial Vein Thrombosis

H.L.A. Yuen^1,2, W. Fang², S. Chunilal^1,2
Abstract Number: PB0604

Variable Findings in One-Stage Clotting Assays in a Patient with Waldenstrom’s Macroglobulinaemia

S. Platton¹, A. McCormick², A. Riddell³, E. Bromidge², C. Fenoo⁴, G.W. Moore^2,5, C. Boshier⁴
Abstract Number: PB1507

Variants in the LLR5 Domain Confer to GPIbα Increased Affinity for VWF: A Novel Case of Platelet-type von Willebrand Disease

L. Bury, E. Falcinelli, H. Kuchi Bhotla, A.M. Mezzasoma, G. Guglielmini, P. Gresele
Abstract Number: PB1446

Variants of GFI1B: Phenotype/Genotype of a Series of 9 New Cases

A. Vincenot¹, E. Lainey², V. Barbay³, E. Demaistre⁴, D. Desprez⁵, C. Lavenu-Bombled⁶, A.M. Ronchetti⁷, M.F. Hurtaud¹
Abstract Number: PB1893

Varied Presentations of TTP

A. Aribandi, C.S. Ranjith
Abstract Number: PB2288

Vein Thrombosis after an Osteopathy Session

V. Kieffer
Abstract Number: PB2297

Venous Involvement in Behcet Disease: Clinical Spectrum and Predictive Factors

M. Kechida, A. Fraj, S. Daada, R. Klii, S. Hammami, I. Khochtali, M. Sassi
Abstract Number: PB2449

Venous Recanalization after a Thromboembolic Event in a North Afriacan Population

M. Mrouki, S. Zrida, Y. Cherif, S. Derbel, F. Ben Dahmen, M. Abdallah
Abstract Number: PB2174

Venous Thromboembolic Risk in Ambulatory Cancer Patients: Awareness Needed!

S. Lopes¹, J. Marinho², L. Vieira¹, F. Azevedo¹, I. Leão², E. Neto², Í. Alonso¹, L. Morais², J. Marques¹, A. Barroso³, H. Coelho⁴, E. Mesquita⁵, T. Costa², D. Ferreira¹
Abstract Number: PB2279

Venous Thromboembolism (VTE) Events in Elective and Emergency Orthopaedic Surgery in a Large Teaching Hospital 2011 to 2019

H. Rowswell, T. Nokes
Abstract Number: PB2126

Venous Thromboembolism (VTE) Events with Cancer as a Risk Factor in a Teaching Hospital: 2015-2019

H. Rowswell, T. Nokes
Abstract Number: PB1294

Venous Thromboembolism (VTE) in Children with Community-acquired Staphylococcus Aureus Bacteremia (CA-SAB) in Children: Risk Factors and Prevalence Study from a Single Pediatric Tertiary Care Center in Argentina

C. Cervio¹, M. Hepner¹, E. Annetta¹, G. Pieroni¹, M.B. Bianco¹, J.P. Frontroth¹, A. Smigliani², M.G. Perez², S. Ruvinsky², G. Sciuccati¹
Abstract Number: PB2141

Venous Thromboembolism in Patients with Cancer in Palliative Care

S. Ayende-Perez¹, A. Peña-Nieves², A. Arcos¹, P. Baz¹, E. Verastegui-Avilés¹, G. Cesarman Maus¹
Abstract Number: PB2372

Venous Thromboembolism in Patients with Renal Transplantation

D. Poli¹, L. Migliaccio², E. Antonucci², L. Biancone³, G. Ghigliotti⁴, G. La Manna⁵, A. Ranghino⁶, P. Rigotti⁷, S. Tentori⁸, M. Zanazzi², G. Palareti²
Abstract Number: PB2421

Venous Thromboembolism Profile and Management Differences between Sexes in a RIETE’s Hospital in Brazil

A.T. Rocha^1,2, M. Pereira de Oliveira¹, A.L. Emídio de Souza¹
Abstract Number: PB2242

Venous Thrombosis-dominant Congenital Dysfibrinogenemia Presenting with Cerebral Venous Sinus Thrombosis

H.I. Lim, M.T. DeSancho
Abstract Number: PB/CO07

Venous Thrombotic Complications in Cancer Patients with SARS-CoV-2 Infection: Report from the COVID-19 and Cancer Consortium (CCC19) Registry Analysis

R. Rosovsky¹, A. Li², A. Desai³, D. Shah⁴, J. Fu⁵, S. Gulati⁶, R. Zon⁷, M. Thompson⁸, P. Grivas⁹, G. de Lima Lopes¹⁰, Y. Shyr¹¹, J. Warner¹¹, A. Khaki⁹, T. Choueiri¹², S. Peters¹³, D. Rivera¹⁴, B. Rini¹¹, G. Lyman¹⁵, J. Connors¹⁶, N. Kuderer¹⁷, on behalf of the COVID-19 and Cancer Consortium (CCC19)
Abstract Number: PB1962

Vessel-On-A-Chip Model Revealing Rapid Offset and Onset Mechanisms of Collagen- and Thrombin-Induced Platelet Activation

I. Provenzale, S.L.N. Brouns, D.I. Fernández, P.E.J. van der Meijden, J.W.M. Heemskerk
Abstract Number: PB1626

Video Rate, High Contrast Morphological Imaging of Blood Thrombus using Label – Free Coherent Optical Scattering and Interferometry (COSI) Microscopy

Y. Zheng¹, S.J. Montague², Y.J. Lim^1,2, T. Xu¹, E.E. Gardiner², W.M. Lee^1,2
Abstract Number: PB2374

Visualization of Thrombin Formation on Activated Platelets and Fibrin Formation in Venous Flow Condition

N. Sugita¹, H. Hirakata², K. Inoue², K. Koike²
Abstract Number: PB1054

Vitamin D Status and Risk of Osteoporosis in Hemophilia Patients

M. Zakaria, M. Badr
Abstract Number: PB1924

Vitamin K Antagonist (VKA) Monitoring Using Point of Care Testing (POCT) in Patients with Antiphospholipid Syndrome (APS)

M. Masucci¹, J. Martin¹, E. Shingleton¹, A. Li Kam Wa¹, Z. Mahir², K. Breen^1,2
Abstract Number: PB2058

Vitamin K Antagonists Dosing According to Pharmacogenetics

E. Ristovska¹, T. Makarovska Bojadjieva¹, E. Velkova², V. Dejanova¹, E. Petkovic¹, R. Grubovic¹
Abstract Number: PB0313

VMX-C001 Is a Reversal Agent for FXa-inhibiting DOACs and Displays a Favorable Pharmacokinetic and Pharmacodynamic Profile

D. Verhoef^1,2, M. Schreuder², K.L. Cheung², M.H.A. Bos², P.H. Reitsma^1,2
Abstract Number: PB1546

von Willebrand Disease Combined with Other Coagulation Defects: Experience at a Single Reference Coagulation Laboratory in Iran

O. Seidi Zadeh, M. Ahmadinejad, S. Homayoun, M. Mojtabavi, S. Mohsenian
Abstract Number: PB0502

Von Willebrand Disease Type 1 Is Associated with Number of Rare Nonsynonymous Variants in the VWF Gene

B. Sadler¹, P. Christopherson², R. Montgomery², J. Di Paola¹, Zimmerman Program Investigators
Abstract Number: PB0146

Von Willebrand Factor (VWF) Deficiency Leads to Altered Angiogenesis in the Gastrointestinal Tract

M. von Depka¹, S. Lehner¹, M. Ekhlasi-Hundrieser¹, C. Pfarrer², C. Detering¹, K. Kaiser^1,2
Abstract Number: OC 01.1

von Willebrand Factor as a Predictor of Mortality and its Target Concentration Dependent Inhibition by BT200 Aptamer in Patients Treated with Potent ADP Receptor Blockers

K. Kovacevic¹, B. Jilma¹, S. Zhu², J. C. Gilbert², M.-P. Winter³, A. Toma³, I. Lang³, C. Hengstenberg³, J. Siller-Matula⁴
Abstract Number: PB0073

Von Willebrand Factor in Stroke and Non-valvular Atrial Fibrillation Patients

M.E. Viveros-Sandoval¹, L. Garcia-Quezada¹, S.E. Lopez Castaneda¹, A. Arauz-Gongora², C.A. Arean-Martinez³
Abstract Number: PB0157

von Willebrand Factor Levels and Expression Pattern Are Altered in Response to Aging

P. Alavi¹, R. Yousef Abdualla¹, S. Bourque², J. Nagendran³, N. Jahroudi¹
Abstract Number: PB1552

von Willebrand Factor Propeptide: Useful Diagnostic Add-On to Differentiate von Willebrand Disease Based upon Increased von Willebrand Factor Clearance

O. Tiebel¹, K. Trautmann-Grill², S. Marten², R. Knöfler³
Abstract Number: PB1592

Von Willebrand’s Disease: A Diagnostic Evaluation Using Current Guidelines

E. Bar¹, S. De Soysa¹, L. Huang¹, E. Symington²
Abstract Number: PB2204

VTE and its complications: A Real World View Daryl Pollock, RN, MN CNS Thrombosis/Haemostasis

D. Pollock
Abstract Number: PB2353

VTE Prophylaxis Performance in a Tertiary and Secondary Level Hospital in Ireland

A. Talbot, L.Y. Tan, R. Tyrrell, M. Mustafa, Y. Ghanem, M. Watts
Abstract Number: PB2477

VTE Treatment in Routine Clinical Practice: A Pre-specified Combined Evaluation of XALIA and XALIA-LEA with Additional Analyses of Special Patient Populations

S. Haas¹, L.G. Mantovani^2,3, R. Kreutz⁴, D. Monje⁵, J. Schneider⁵, E. Zell⁶, M. Tamm⁷, M. Gebel⁷, J.-P. Bugge⁵, W. Ageno⁸, A.G.G. Turpie⁹